Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Renou

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Emerging Infectious Diseases|January 25, 2008
Possible zoonotic transmission of hepatitis E from pet pig to its ownerChristophe Renou, Jean-Francois Cadranel, Marc Bourlière, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trialClaire Wartelle-Bladou, Jean-Pierre Arpurt, Christophe Renou, et al.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2014
Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infectionSarah Aherfi, Patrick Borentain, Ferdaous Raissouni, et al.
Biomedicines|March 29, 2023
Mid-Infrared Spectroscopy as a New Tool for Ruling Out Spontaneous Bacterial Peritonitis: A Proof-of-Concept StudyMarwin A Farrugia, Maëna Le Corvec, Christophe Renou, et al.
Gastroenterology|October 13, 2006
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirinJean-Pierre Bronowicki, Denis Ouzan, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2019
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patientsArmand Garioud, Ratmony Heng, Xavier Amiot, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitisVlad Ratziu, Muhammad Y Sheikh, Arun J Sanyal, et al.
The American Journal of Gastroenterology|March 18, 2006
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca studyPhilippe Halfon, Marc Bourliere, Romaric Deydier, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive TherapyIlias Kounis, Christophe Renou, Stephane Nahon, et al.
Presse Medicale (Paris, France : 1983)|March 12, 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)Alexandre Pariente, Jean-Pierre Arpurt, André-Jean Rémy, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Emerging Infectious Diseases|January 25, 2008
Possible zoonotic transmission of hepatitis E from pet pig to its ownerChristophe Renou, Jean-Francois Cadranel, Marc Bourlière, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trialClaire Wartelle-Bladou, Jean-Pierre Arpurt, Christophe Renou, et al.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2014
Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infectionSarah Aherfi, Patrick Borentain, Ferdaous Raissouni, et al.
Biomedicines|March 29, 2023
Mid-Infrared Spectroscopy as a New Tool for Ruling Out Spontaneous Bacterial Peritonitis: A Proof-of-Concept StudyMarwin A Farrugia, Maëna Le Corvec, Christophe Renou, et al.
Gastroenterology|October 13, 2006
Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirinJean-Pierre Bronowicki, Denis Ouzan, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2019
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patientsArmand Garioud, Ratmony Heng, Xavier Amiot, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitisVlad Ratziu, Muhammad Y Sheikh, Arun J Sanyal, et al.
The American Journal of Gastroenterology|March 18, 2006
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca studyPhilippe Halfon, Marc Bourliere, Romaric Deydier, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive TherapyIlias Kounis, Christophe Renou, Stephane Nahon, et al.
Presse Medicale (Paris, France : 1983)|March 12, 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)Alexandre Pariente, Jean-Pierre Arpurt, André-Jean Rémy, et al.
Pageof 6